标题
Emerging drugs for the treatment of chronic pruritic diseases
作者
关键词
-
出版物
EXPERT OPINION ON EMERGING DRUGS
Volume -, Issue -, Pages 1-12
出版商
Informa UK Limited
发表日期
2020-07-25
DOI
10.1080/14728214.2020.1801632
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Role of neuroimmune circuits and pruritus in psoriasis
- (2020) Marissa T. Ayasse et al. EXPERIMENTAL DERMATOLOGY
- Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
- (2020) Hidemi Nakagawa et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Serlopitant for Psoriatic Pruritus: a Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2020) David M. Pariser et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Effects of Ruxolitinib Cream on Pruritus and Quality of Life in Atopic Dermatitis: Results From a Phase 2, Randomized, Dose-Ranging, Vehicle- and Active-Controlled Study
- (2020) Brian S. Kim et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis
- (2020) Sonja Ständer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Itch: An Under-recognized Problem in Psoriasis
- (2019) Boni Elewski et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial
- (2019) Sonja Ständer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Willingness to pay and quality of life in patients with pruritic skin disorders
- (2019) Maria Stefanidou et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Chronic itch management: therapies beyond those targeting the immune system
- (2019) Emilie Fowler et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis
- (2019) G. Yosipovitch et al. BRITISH JOURNAL OF DERMATOLOGY
- Itching as a systemic disease
- (2019) Takashi Hashimoto et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Chronic Kidney Disease‐Associated Pruritus and Quality of Life in Malaysian Patients Undergoing Hemodialysis
- (2019) Inayat U Rehman et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
- (2019) Jonathan I. Silverberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Neuroimmune Interactions in Chronic Itch of Atopic Dermatitis
- (2019) G. Yosipovitch et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream
- (2019) Brian S. Kim et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Upadacitinib in Adults With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Randomized, Placebo-Controlled Trial
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Ligelizumab for Chronic Spontaneous Urticaria
- (2019) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus
- (2019) Steven Fishbane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis
- (2019) Melinda J. Gooderham et al. JAMA Dermatology
- Substance P Antagonist Aprepitant Shows no Additive Effect Compared with Standardized Topical Treatment Alone in Patients with Atopic Dermatitis
- (2018) L Lönndahl et al. ACTA DERMATO-VENEREOLOGICA
- Management of Chronic Hepatic Itch
- (2018) Miriam M. Düll et al. DERMATOLOGIC CLINICS
- Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study
- (2018) Kenji Kabashima et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
- (2018) Andreas Wollenberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States
- (2018) Jashin J. Wu et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe Itch
- (2018) Leigh A. Nattkemper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Prevalence and Characteristics of Pruritus and Association With Quality of Life in People Living With HIV: A Cross-Sectional Study
- (2018) Thomas Xu et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial
- (2018) Gil Yosipovitch et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
- (2018) Emma Guttman-Yassky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries
- (2018) E. Brenaut et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis
- (2018) Eric L. Simpson et al. JAMA Dermatology
- Tradipitant improves worst itch and disease severity in patients with chronic pruritus related to atopic dermatitis
- (2018) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial
- (2018) Sabine Steinke et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis
- (2018) Samer Al-Dury et al. Scientific Reports
- Aprepitant for the Treatment of Pruritus in Sézary Syndrome
- (2018) John A. Zic et al. JAMA Dermatology
- The role of the histamine H4 receptor in atopic dermatitis and psoriasis
- (2018) Katrin Schaper-Gerhardt et al. BRITISH JOURNAL OF PHARMACOLOGY
- Atopic dermatitis: a review of evolving targeted therapies
- (2018) Kadra Kalamaha et al. Expert Review of Clinical Immunology
- Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis
- (2018) Thomas Werfel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Itch: From mechanism to (novel) therapeutic approaches
- (2018) Gil Yosipovitch et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tezepelumab, an anti-TSLP monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Topical E6005/RVT-501, a novel phosphodiesterase 4 inhibitor, for the treatment of atopic dermatitis
- (2017) Masutaka Furue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
- (2017) Ana Duarte et al. HEALTH TECHNOLOGY ASSESSMENT
- Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway
- (2017) Hongfei Lou et al. JOURNAL OF IMMUNOLOGY
- JAK inhibitors in dermatology: The promise of a new drug class
- (2017) William Damsky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Janus kinase inhibitors in dermatology: A systematic review
- (2017) Rony Shreberk-Hassidim et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Phase I randomized study of KHK4083, an anti-OX40 monoclonal antibody, in patients with mild to moderate plaque psoriasis
- (2017) K.A. Papp et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study
- (2017) Vinod S Hegade et al. LANCET
- Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
- (2017) Thomas Ruzicka et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aprepitant for the Treatment of Chronic Refractory Pruritus
- (2017) Alice He et al. Biomed Research International
- Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin
- (2016) L Nattkemper et al. ACTA DERMATO-VENEREOLOGICA
- Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis
- (2016) A.B. Kimball et al. BRITISH JOURNAL OF DERMATOLOGY
- A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study
- (2016) Jon M. Hanifin et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Retrospective analysis of data from an itch center: Integrating validated tools in the electronic health record
- (2016) Nicholas K. Mollanazar et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis
- (2015) D Roblin et al. ACTA DERMATO-VENEREOLOGICA
- Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
- (2015) Nicholas K. Mollanazar et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Effect of topical phosphodiesterase 4 inhibitor E6005 on Japanese children with atopic dermatitis: Results from a randomized, vehicle-controlled exploratory trial
- (2015) Osamu Nemoto et al. JOURNAL OF DERMATOLOGY
- Biologic therapy for psoriasis - still searching for the best target
- (2014) Teresa Pinto-Almeida et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects
- (2014) J. P. Arm et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo
- (2014) Atsuo Tanimoto et al. INFLAMMATION RESEARCH
- Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis
- (2014) Yoko Murata et al. JOURNAL OF DERMATOLOGY
- Safety of dermatologic medications in pregnancy and lactation
- (2014) Jenny E. Murase et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Histamine receptor H4 regulates mast cell degranulation and IgE induced FcεRI upregulation in murine bone marrow-derived mast cells
- (2013) Arash Mirzahosseini et al. CELLULAR IMMUNOLOGY
- CD8+ T Cells in the Lesional Skin of Atopic Dermatitis and Psoriasis Patients Are an Important Source of IFN-γ, IL-13, IL-17, and IL-22
- (2012) DirkJan Hijnen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Impact of Pruritus on Quality of Life
- (2011) Seema P. Kini ARCHIVES OF DERMATOLOGY
- The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis
- (2011) S. P. Jariwala et al. CLINICAL AND EXPERIMENTAL ALLERGY
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
- (2009) Kristine E. Nograles et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Itch characteristics in atopic dermatitis: results of a web-based questionnaire
- (2008) A. Dawn et al. BRITISH JOURNAL OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search